Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Cynthia Rudin, PhD, is a highly regarded computer scientist who’s been eyeing the advance of artificial intelligence into society with equal parts enthusiasm and concern.
By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public.
Royal Philips Electronics plans to work with Nuvodia, a wholly owned subsidiary of Inland Imaging Investments, to bring Philips PACS to rural hospitals, smaller institutions, imaging centers, orthopedic centers and oncology practices.
Mobile phone-based software may allow physicians to manage and consult on stroke cases in real time from anywhere in the world, according to a study presented at the ninth annual meeting of the Society of NeuroInterventional Surgery in San Diego.
The FDA has cleared Covidien to sell a new bedside monitor that continuously checks oxygen saturation and pulse rate for adult, pediatric and neonatal patients. The company announced the 510(k) approval July 30, stating that its Nellcor Bedside SpO2 system with OxiMax technology helps enable clinicians to detect variations sooner than previous models.
Mobile health application (app) store Happtique is seeking public comment on a recently published draft of standards for its app certification program.
BOSTONTexting is gaining traction in healthcare. While much of the buzz at the 4th annual mHeatlh World Congress focused on the potential of smartphone applications to engage patients, two presentations told how public health initiatives are having success with the slightly older technology.
The FDA has approved the use of Bracco Diagnostics' MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in MR angiography to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.
BOSTONThe growth in smart phone adoption and a shift to a mobile, social media based model of consumer engagement means rethinking how and when patient engagement can occur, according to a panel discussion on July 26 at the 4th Annual mHealth World Congress.
